911
Views
73
CrossRef citations to date
0
Altmetric
Review

Solid lipid microparticles as an approach to drug delivery

, &

Bibliography

  • Mehnert W, Mäder K. Solid lipid nanoparticles. Production, characterization and applications. Adv Drug Del Rev 2001;47:165-96
  • Papakostas D, Rancan F, Sterry W, et al. Nanoparticles in dermatology. Archiv Dermatol Res 2011;303:533-50
  • Jaspart S, Piel G, Delattre L, et al. Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications. Expert Opin Drug Deliv 2005;2:75-87
  • Üner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomed 2007;2:289-300
  • Prow TW, Grice JE, Lin LL, et al. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev 2011;63:470-91
  • Müller RH, Mehnert W, Lucks JS, et al. Solid lipid nanoparticles (SLN) – An alternative colloidal carrier system for controlled drug delivery. Eur J Pharm Biopharm 1995;41:62-9
  • Elgart A, Cherniakov I, Aldouby Y, et al. Lipospheres and pro-nano lipospheres for delivery of poorly water soluble compounds. Chem Phys Lipids 2012;165:438-53
  • Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carrier (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002;54:S131-55
  • Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm 2009;366:170-84
  • Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm 2000;50:161-77
  • Mezzena M, Scalia S, Young PM, et al. Solid lipid budesonide microparticles for controlled release inhalation therapy. AAPS J 2009;11:771-8
  • Tursilli R, Piel G, Delattre L, et al. Solid lipid microparticles containing the sunscreen agent, octyl-dimethylaminobenzoate: effect of the vehicle. Eur J Pharm Biopharm 2007;66:483-7
  • Dalpiaz A, Mezzena M, Scatturin A, et al. Solid lipid microparticles for the stability enhancement of the polar drug N(6)-cyclopentyladenosine. Int J Pharm 2008;355:81-6
  • Scalia S, Salama R, Young PM, et al. Preparation and in vitro evaluation of salbutamol-loaded lipid microparticles for sustained release pulmonary therapy. J Microencapsul 2012;29:225-33
  • Amstrong DJ, Elliott PNC, Ford JL, et al. Poly(DL-lactic acid) microspheres incorporating histological dyes for intra-pulmonary histopathological investigations. J Pharm Pharmacol 1996;48:258-62
  • Müller RH, Maaβen H, Weyhers F, et al. Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles. Int J Pharm 1996;138:85-94
  • Edwards DA, Hanes J, Caponetti G, et al. Large porous particles for pulmonary drug delivery. Science 1997;276:1868-71
  • EC- SCENIHR (Scientific Committee on Emerging and Newly Identified Health Risks). Opinion on the scientific basis for the definition of the term “nanomaterial”. European Commission. Directorate General for Health & Consumers. 2010
  • Cavc G, Vierl U. Nanotechnology and the transdermal route. A state of art review and critical appraisal. J Control Release 2010;141:277-99
  • Singh MR, Pradhan K, Singh D. Lipid matrix systems with emphasis on lipid microspheres: potent carriers for transcutaneous delivery of bioactives. Current Drug Deliv 2012;9:243-54
  • Bose S, Du Y, Takhistov P, et al. Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems. Int J Pharm 2013;441:56-66
  • Müller RH, Petersen RD. Hommoss a, et al. Nanostructured lipid carrier (NLC) in cosmetic dermal products. Adv Drug Deliv Rev 2007;59:522-30
  • Schäfer-Korting M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev 2007;59:427-43
  • Parhi R, Suresh P. Preparation and characterization of solid lipid nanoparticles - a review. Current Drug Discov Technol 2012;9:2-16
  • Schwarz C, Mehnert W, Lucks JS, et al. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J Control Release 1994;30:83-96
  • Scalia S, Mezzena M, Ramaccini D. Encapsulation of the UV filters ethylhexyl methoxycinnamate and butyl methoxydibenzoylmethane in lipid microparticles: effect on in vivo human skin permeation. Skin Pharmacol Physiol 2011;24:182-9
  • Teskač K, Kristl J. The evidence of solid lipid nanoparticles mediated cell uptake of resveratrol. Int J Pharm 2010;390:61-9
  • Nasr M, Mansour S, Mortada ND, et al. Lipospheres as carrier for topical delivery of aceclofenac: preparation, characterization and in vivo evaluation. AAPS PharmSciTech 2008;9:154-62
  • Zhang L, Qian Y, Long C, et al. Systematic procedures for formulation design of drug-loaded solid lipid microparticles: selection of carrier material as stabilizer. Ind Eng Chem Res 2008;47:6091-100
  • Sharma P, Ganta S, Denny WA, et al. Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: chlorambucil. Int J Pharm 2009;1:15-26
  • Venkateswarlu V, Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release 2004;95:627-38
  • Bhalekar M, Pokharkar V, Madgulkar et al. Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery. AAPS PharmSciTech 2009;10:289-96
  • Savolainen M, Khoo C, Glad H, et al. Evaluation of controlled-release polar lipid microparticles. Int J Pharm 2002;244:151-61
  • Singh MR, Singh D, Swarnlata S. Development and in vitro evaluation of polar lipid based liposheres for oral delivery of peptide drugs. Intern J Drug Deliv 2009;1:15-26
  • Rohit B, Kaur Indu P. A method to prepare solid lipid nanoparticles with improved entrapment efficiency of hydrophilic drugs. Curr Nanosci 2013;9:211-20
  • Scalia S, Mezzena M. Co-loading of a photostabilizer with the sunscreen agent, butyl methoxydibenzoylmethane in solid lipid microparticles. Drug Dev Ind Pharm 2009;35:192-8
  • Jaspart S, Bertholet P, Piel G, et al. Solid lipid microparticles as a sustained release system for pulmonary drug delivery. Eur J Pharm Biopharm 2007;65:47-56
  • Dalpiaz A, Cacciari B, Mezzena M, et al. Solid lipid microparticles for the stability enhancement of a dopamine prodrug. J Pharm Sci 2010;99:4730-7
  • Malzert-Fréon A, Saint-Lorant G, Hennequin D, et al. Influence of the introduction of a solubility enhancer on the formulation of lipidic nanoparticles with improved drug loading rates. Eur J Pharm Biopharm 2010;75:117-27
  • Ekambaram P, Sathali AAH, Priyanka K. Solid lipid nanoparticles. A review Sci Resv Chem Commun 2012;2:80-102
  • Siekmann B, Westensen K. Melt-homogenized solid lipid nanoparticles stabilized by the non-ionic surfactant tyloxapol. Preparation and particle size determination. Pharm Pharmacol Lett 1994;3:194-7
  • McCarron PA, Donnelly RF, Al-Kassas R. Comparison of a novel spray congealing procedure with emulsion-based methods for the micro-encapsulation of water-soluble drugs in low melting point triglycerides. J Microencapsul 2008;25:365-78
  • Scalia S, Trotta V, Traini D, et al. Incorporation of quercetin in respirable lipid microparticles: effecr on stability and cellular uptake on A549 pulmonary alveolar epithelial cells. Colloids Surf B 2013;112:322-9
  • Chen-yu G, Chun-fen Y, Qi-lu L, et al. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int J Pharm 2012;430:292-8
  • Cortesi R, Eposito E, Luca G, et al. Production of lipospheres as carriers for bioactive compounds. Biomaterials 2002;23:2283-94
  • Yener G, Incegül T, Yener N. Importance of using solid lipid microspheres as carriers for UV filters on the example octyl methoxy cinnamate. Int J Pharm 2003;258:203-7
  • Mestres JP, Duracher L, Baux C, et al. Benzophenone-3 entrapped in solid lipid microspheres. Int J Pharm 2010;400:1-7
  • Trotta M, Cavalli R, Carlotti ME, et al. Solid lipid microparticles carrying insulin formed by solvent-in-water emulsion-diffusion technique. Int J Pharm 2005;288:281-8
  • Singh MR, Pradhan K, Singh D. Lipid matrix systems with emphasis on lipid microspheres. Potent carriers for transcutaneous delivery of bioactives. Curr Drug Deliv 2012;9:243-54
  • Passerini N, Perissutti B, Albertini B, et al. Controlled release of verapamil hydrochloride from waxy microparticles prepared by spray congealing. J Control Rel 2003;88:263-75
  • Scalia S, Traini D, Young PM, et al. Comparison of spray congealing and melt emulsification methods for the incorporation of the water-soluble salbutamol sulphate in lipid microparticles. Pharm Develop Technol 2013;18:266-73
  • Rodriguez L, Passerini N, Cavallari C, et al. Description and preliminary evaluation of a new ultrasonic atomizer for spray-congealing processes. Int J Pharm 1999;183:133-43
  • Albertini A, Mezzena M, Passerini N, et al. Evaluation of spray congealing as technique for the preparation of highly loaded solid lipid microparticles containing the sunscreen agent. avobenzone. J Pharm Sci 2009;98:2759-69
  • Debenedetti PG, Tom JW, Yeo SD, Lim GB. Application of supercritical fluids for the production of sustained delivery devices. J Control Release 1993;24:27-44
  • Subramanian B, Rajewski RA, Snavely K. Pharmaceutical processing with supercritical carbon dioxide. J Pharm Sci 1997;86:885-90
  • Santos IRD, Richard J, Pech B, et al. Microencapsulation of protein particles within lipids using a novel supercritical fluid process. Int J Pharm 2002;242:69-78
  • Sampaio de Sousa AR, Simplicio AL, Herminio de Sousa C, et al. Preparation of glyceryl monostearate-based particles by PGSS - application to caffeine. J Supercritical Fluids 2007 43:120-5
  • Vezzù K, Campolmi C, Bertucco A. Production of lipid microparticles magnetically active by a supercritical fluid-based process. Int J Chem Eng 2009;2009:article ID 781247
  • Segale L, Mannina P, Giovannelli L, et al. A novel dense CO2 supercritical fluid technology for the development of microparticulate delivery systems containing ketoprofen. European J Pharm Biopharm 2012;82:491-7
  • Vijayaraghavan M, Stolnik S, Howdle SM, et al. Suitability of polymer materials for production of pulmonary microparticles using a PGSS supercritical fluid technique: preparation of microparticles using PEG, fatty acids and physical and chemical blend of PEG and fatty acids. Int J Pharm 2013;441:580-8
  • Eldem T, Speiser P, Hincal A. Optimization of spray-dried and -congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy. Pharm Res 1991;8:47-54
  • Reithmeier H, Herrmann J, Gopferich A. Development and characterization of lipid microparticles as a drug carrier for somatostatin. Int J Pharm 2001;218:133-43
  • Schubert MA, Harms M, Müller-Goyman CC. Structural investigations on lipid nanoparticles containing high amounts of lecitin. Eur J Pharm Sci 2006;27:226-36
  • Keck MC. Particle size analysis of nanocrystals: improved analysis method. Int J Pharm 2010;390:3-12
  • Martin A. Physical pharmacy. 4th Edition. Lea & Febiger; Malvern, PA: 1993. p. 398:431
  • Chen H, Chang X, Du D, et al. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. J Control Release 2006;110:296-306
  • Upadhyay D, Scalia S, Vogel R, et al. Magnetised Thermo responsive lipid vehicles for targeted and controlled lung drug delivery. Pharm Res 2012;29:2456-67
  • Iannuccelli V, Sala N, Tursilli R, et al. Influence of liposphere preparation on butyl-methoxydibenzoylmethane photostability. Eur J Pharm Biopharm 2006;63:140-5
  • USP XXI. United States Pharmacopoeia Convention; Rockville, MD, USA 1985. 1281
  • Passerini N, Qi S, Albertini B, et al. Solid lipid microparticles produced by spray congealing: influence of the atomizer on the microparticle characteristics and mathematical modeling of drug release. J Pharm Sci 2010;99:916-31
  • Wartewig S, Neubert RH. Pharmaceutical applications of Mid-IR and Raman spectroscopy. Adv Drug Deliv Rev 2005;57:1144-70
  • Iannuccelli V, Coppi G, Sergi S, et al. In vivo and in vitro skin permeation of butyl methoxydibenzoylmethane from lipospheres. Skin Pharmacol Physiol 2008;21:30-8
  • Barras A, Mezzetti A, Richarda A, et al. Formulation and characterization of polyphenol-loaded lipid nanocapsules. Int J Pharm 2009;379:270-7
  • Fricker G, Kromp T, Wendel A, et al. Phospholipids and lipid-based formulations in oral drug delivery. Pharm Res 2010;27:1469-86
  • Dalpiaz A, Ferraro L, Perrone D, et al. Brain uptake of a zidovudine prodrug after nasal administration of solid lipid microparticles. Mol Pharmaceutics 2014;11:1550-61
  • Sebti T, Amigi K. Preparation and in vivo evaluation of lipidic carriers and fillers for inhalation. Eur J Pharm Biopharm 2006a;63:51-8
  • Nassimi M, Schleh C, Lauenstein HD, et al. A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung. Eur J Pharm Biopharm 2010;75:107-16
  • Scalia S, Haghi M, Losi V, et al. Quercetin solid lipid microparticles : a flavonoid for inhalation lung delivery. Eur J Pharm Sci 2013c;49:278-85
  • Maretti E, Rossi T, Bondi M, et al. Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis. Int J Pharm 2014;462:74-82
  • Erni C, Suard C, Freitas S, et al. Evaluation of cationic solid lipid microparticles as synthetic carriers for the targeted delivery of macromolecules to phagocytic antigen-presenting cells. Biomaterials 2002;23:4667-76
  • Schöler N, Zimmermann E, Katzfey U, et al. Effect of solid lipid nanoparticles (SLN) on cytokine production and the viability of murine peritoneal macrophages. J Microencaps 2000;17:639-50
  • Reithmeier H, Herrmann J, Gopferich A. Lipid microparticles as a parental controlled release device for peptides. J Control Release 2001b;73:339-50
  • Sanna V, Kirschvink N, Gustin P, et al. Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS PharmSciTech 2004;5:17-23
  • Schwab M, Sax G, Schulze S, et al. Studies on the lipase induced degradation of lipid based drug delivery systems. J Control Release 2009;140:27-33
  • Peetla C, Labhasetwar V. Biophysical characterization of nanoparticle-endothelial model cell membrane interactions. Mol Pharmaceutics 2008;5:418-29
  • Koane D. Microparticles and nanoparticles for drug delivery. Biotech Bioeng 2007;96:203-9
  • Demirel M, Yazan Y, Müller RH, et al. Formulation and in vitro-in vivo evaluation of piribedil solid lipid micro- and nano-particles. J Microencapsul 2001;18:359-71
  • Harde H, Das M, Jain S. Solid lipid nanoparticles. An oral bioavailability enhancer vehicle. Expert Opin Drug Deliv 2011;8:1407-24
  • Zimmermann E, Müller RH. Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle dispersions in artificial gastrointestinal media. Eur J Pharm Biopharm 2001;52:203-10
  • Singh MR, Singh D, Swarnlata S. Development and in vitro evaluation of polar lipid based liposheres for oral delivery of peptide drugs. Intern J Drug Deliv 2009;1:15-26
  • Nnamani PO, Attama AA, Ibezim EC, et al. SRMS142-based solid lipid microparticles: application in oral delivery of glibenclamide to diabetic rats. Eur J Pharm Biopharm 2010;76:68-74
  • Momoh MA, Kenechukwu FC, Attama AA. Formulation and evaluation of novel solid lipid microparticles as a sustained release system for the delivery of metformin hydrochloride. Drug Deliv 2013;20:102-11
  • Chime SA, Attama AA, Builders PF, et al. Sustained-release diclofenc-potassium solid lipid microparticles based on solidified reverse micelle solution: in vitro and in vivo evaluation. J Microencapsul 2013;30:335-45
  • Balducci AG, Colombo G, Corace G, et al. Layered lipid microcapsules for mesalazine delayed-release in children. Int J Pharm 2011;421:293-300
  • Milak S, Medlicott N, Tucker IG. Solid lipid microparticles containing loratadine prepared using a micromixer. J Microencapsul 2006;23:823-31
  • Toll R, Jacobi U, Richter H, et al. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J Invest Dermatol 2004;123:168-76
  • Baroli B. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? J Pharm Sci 2010;99:21-50
  • Lademann J, Weigmann HJ, Rickmeyer C, et al. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol 1999;12:247-56
  • Lademann J, Schaefer H, Otberg N, et al. Penetration of microparticles into human skin. Hautarzt 2004;55:1117-19
  • Lademann J, Ritchter H, Teichmann A, et al. Nanoparticles - an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm 2007;66:159-64
  • Passerini N, Gavini E, Albertini B, et al. Evaluation of solid lipid microparticles produced by spray congealing for topical application of econazole nitrate. J Pharm Pharmacol 2009;61:559-67
  • Lauterbach A, Mueller-Goymann CC. Development, formulation and characterization of an adapalene-loaded solid lipid microparticles dispersion for follicular penetration. Int J Pharm 2014;466:122-32
  • Scalia S, Mezzena M, Iannuccelli V. Influence of solid lipid microparticle carriers on skin penetration of the sunscreen agent, 4-methylbenzylidene camphor. J Pharm Pharmacol 2007;59:1621-7
  • Pandey R, Khuller GK. Solid lipid particle-based inhalable sustained drug delivery system against experimental tuberculosis. Tuberculosis 2005;85:227-34
  • Sebti T, Pilcer G, Van Gansbeke et al. Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation. Eur J Pharm Biopharm 2006;64:26-32
  • Buttini F, Colombo P, Rossi A, et al. Particles and powders: tools for innovation for non-invasive drug administration. J Control Rel 2012;161:693-702
  • Kippax P, Suman J, Williams G. Understanding the requirements for effective nasal drug delivery. Pharm Technol 2010;9:58-64
  • Saraf S, Mishra D, Asthana A, et al. Lipid microparticles for mucosal immunization against hepatitis B. Vaccines 2006;24:45-56
  • Domb AJ. Long acting injectable oxytetracycline-liposphere formulation. Int J Pharm 1995;124:271-8
  • Del Curto MD, Chicco D, D’Antonio M, et al. Lipid microparticles as sustained release system for a GnRH antagonist (Antanide). J Control Release 2003;89:297-310

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.